Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03425422 · ClinicalTrials.gov registry record · NA
ANTHEM-HFrEF Pivotal Study
A NA study, sponsored by LivaNova.
- Terminated
- Registry status
- NA
- Development phase
- 533
- Enrollment target
NCT03425422 is a NA study that was terminated before completion, run by LivaNova. The registered enrollment target is 533 participants.
The verdict
NCT03425422, a NA study, was terminated before completion, sponsored by LivaNova.
- TERMINATED
- Registry status
- NA
- Development phase
- 533 participants
- Enrollment target
Study Summary
A multi-center randomized controlled clinical trial to evaluate Autonomic Regulation Therapy with the VITARIA system in patients with symptomatic heart failure and reduced ejection fraction.
Interventions
- DEVICE VITARIA System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 533 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03425422
The ClinicalTrials.gov registry entry for NCT03425422 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 533 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LivaNova, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VITARIA System is the first listed.
NCT03425422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03425422 about?
NCT03425422 is a clinical study titled "ANTHEM-HFrEF Pivotal Study". A multi-center randomized controlled clinical trial to evaluate Autonomic Regulation Therapy with the VITARIA system in patients with symptomatic heart failure and reduced ejection fraction.
What is the current status of trial NCT03425422?
This trial is currently terminated. It is a NA study. The enrollment target is 533 participants. The study started on 2018-05-01. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT03425422?
The interventions under investigation include: VITARIA System (DEVICE).
Who is sponsoring clinical trial NCT03425422?
This trial is sponsored by LivaNova, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.